We are live on ! Find out more
THRD

Third Harmonic Bio

Delisted

THRD was delisted on the 30th of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$107M -$6.3M -505,573 -5%
O
2
OrbiMed
New York
$59.5M
GA
3
General Atlantic
New York
$34.7M +$5.15M +413,561 +14%
EC
4
EcoR1 Capital
California
$32.7M
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$30.1M +$1.24M +99,250 +4%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$26.1M +$27.8M +2,228,549 +724%
TCM
7
TCG Crossover Management
California
$25.8M +$1.13M +90,424 +4%
BI
8
BVF Inc
California
$24.4M -$24.8M -1,993,000 -46%
BCM
9
Boxer Capital Management
California
$20.6M +$24.9M +2,000,000 New
BlackRock
10
BlackRock
New York
$15.2M +$251K +20,154 +1%
Vanguard Group
11
Vanguard Group
Pennsylvania
$10.6M +$1.72M +138,338 +16%
DM
12
Deerfield Management
New York
$10.5M +$12.7M +1,019,700 New
RCM
13
RA Capital Management
Massachusetts
$9.88M -$3.99M -320,206 -25%
Millennium Management
14
Millennium Management
New York
$6.59M +$6.96M +558,616 +686%
NCM
15
Nantahala Capital Management
Connecticut
$5.16M +$6.24M +501,000 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.96M +$518K +41,537 +9%
State Street
17
State Street
Massachusetts
$4.34M +$265K +21,301 +5%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$3.73M +$4.51M +361,890 New
SSA
19
Schonfeld Strategic Advisors
New York
$3.32M +$821K +65,900 +26%
CC
20
Commodore Capital
New York
$2.45M -$14M -1,122,865 -83%
Northern Trust
21
Northern Trust
Illinois
$1.98M +$11.3K +903 +0.5%
Charles Schwab
22
Charles Schwab
California
$1.78M +$381K +30,611 +21%
Morgan Stanley
23
Morgan Stanley
New York
$1.67M -$6.14K -493 -0.3%
TCM
24
Tang Capital Management
California
$1.54M +$1.87M +150,000 New
Renaissance Technologies
25
Renaissance Technologies
New York
$1.31M +$287K +23,046 +22%